Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:45 PM
Ignite Modification Date:
2025-12-24 @ 6:45 PM
NCT ID:
NCT02213757
Eligibility Criteria:
Inclusion Criteria:
* Post-menopausal women
* Asymptomatic microscopic hematuria (three or more red blood cells per high powered field on a single urine microscopy) in the absence of urinary tract infection.
Exclusion Criteria:
* Known urologic disease
* Presence of gross hematuria
* Presence of indwelling urologic foreign body (foley catheter, ureteral stent)
* Inability to obtain intravenous contrast CT scan (elevated creatinine, severe contrast allergy)
* History of pelvic irradiation or malignancy
* Not a candidate for vaginal estrogen
* Allergy to vaginal estrogen
* Current or prior diagnosis of breast or endometrial cancer
* History of deep vein thrombosis/pulmonary embolus
* Hypercoagulable state
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT02213757
Study Brief:
Protocol Section:
NCT02213757